Search

everythinglearnresearchcommunity

for

Search:↓

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Higher nitric oxide synthase levels in the scalp may influence hair loss in androgenetic alopecia.

Melanoma risk tools need improvement, certain gene mutations cause skin diseases and could be treated by targeting those mutations, skin wrinkling may relate to lung aging due to genetic factors, and oxidative stress affects hair loss but can be reduced in low oxygen.

Certain gene variations may increase the risk of alopecia, and platelet-rich plasma treatment can improve hair density in those with hair loss; a rare case of facial Becker's nevus was linked to uneven beard growth.

Taking metformin with intense pulsed light therapy improves hair removal for women with PCOS.

CAG repeat numbers in the AR gene likely don't affect male pattern baldness in Korean men.

Androgen receptor expression is similar in affected and unaffected scalp areas in androgenetic alopecia.

Different hair growth phases affect how follicles respond to X-rays, and hormones like testosterone and dihydrotestosterone play a key role in baldness; transplanted hair can grow on bald scalp areas.

The Ar/miR-221/IGF-1 pathway is involved in male pattern baldness, with miR-221 potentially being a new target for treatment.

Testosterone levels influence male behaviors and physical traits, but this relationship is complex and influenced by both internal and external factors.

Caffeine improves male skin's barrier function.

High TNF-α levels may increase hair loss risk after PRP therapy.

Doctors should diagnose hair loss by examining the patient and possibly doing tests, and then treat it based on the type, which may prevent permanent hair loss.

PCOS causes skin issues like excess hair, acne, and hair loss, needing a team approach for treatment.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

The human sebocyte culture model has improved understanding of oily skin and acne, and how they can be treated.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Lack of 5α-Reductase type 1 can lead to insulin resistance and liver problems.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Epitestosterone may counteract testosterone's effects and has roles in body processes like prostate growth and hair distribution.

SHBG may be a useful early indicator and treatment target for PCOS.

Researchers found 71 genetic regions linked to male pattern baldness, which account for 38% of its genetic risk.

PCOS affects multiple organs and requires combined treatment with lifestyle changes, metformin, and oral contraceptives.